Tag: axonics

Axonics announces FDA approval for the use of full-body MRI for...

Axonics have announced that the Food & Drug Administration (FDA) approved the use of full-body magnetic resonance imaging (MRI) using 1.5 Tesla MRI scanners...

Welkin Health announces partnership to implement a programme to support commercialisation...

Welkin Health, a privately-held patient relationship management software company has announced that it is partnering with Axonics, a company focused on the design, development,...

Axonics granted full-body MR-conditional CE mark for its sacral neuromodulation system

Axonics has announced that it has received CE mark approval for 1.5T and 3T full-body magnetic resonance imaging conditional labelling for the Axonics r-SNM...

Axonics announce positive clinical data from its ARTISAN sacral neuromodulation pivotal...

Axonics has disclosed positive top-line results from the ARTISAN-SNM pivotal study, designed to gain marketing approval from the US Food and Drug Administration (FDA)...

Axonics secures US$40M financing to commercialise neuromodulation device

Axonics has secured US$40 million to support commercialisation of its neuromodulatory treatment of urinary and bowel dysfunction. The financing comes as Axonics closes in on the...